PICCIOTTO, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 3.818
AS - Asia 59
SA - Sud America 21
NA - Nord America 2
Totale 3.900
Nazione #
IT - Italia 3.817
CN - Cina 45
BR - Brasile 13
VN - Vietnam 9
AR - Argentina 5
SG - Singapore 3
US - Stati Uniti d'America 2
AM - Armenia 1
CO - Colombia 1
EC - Ecuador 1
ID - Indonesia 1
PY - Paraguay 1
RU - Federazione Russa 1
Totale 3.900
Città #
Genoa 2.038
Genova 938
Rapallo 425
Vado Ligure 409
Beijing 23
Bordighera 7
Ho Chi Minh City 5
Singapore 3
São Paulo 3
Ashburn 2
Buenos Aires 2
Asunción 1
Belo Horizonte 1
Blumenau 1
Boca Toma 1
Bogotá 1
Goiânia 1
Guayaquil 1
Haiphong 1
Hanoi 1
Hải Dương 1
Kostroma 1
Laferrere 1
Matias Barbosa 1
Passos 1
Petrolina 1
Piracicaba 1
Rio de Janeiro 1
Salvador 1
Serra 1
Thái Bình 1
Yerevan 1
Totale 3.876
Nome #
Homocysteine exchange across skeletal muscle in patients with chronic kidney disease 280
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease 147
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 145
The Organ Handling of Soluble Klotho in Humans 134
Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD 128
Impaired Left Ventricular Global Longitudinal Strain among Patients with Chronic Kidney Disease and End-Stage Renal Disease and Renal Transplant Recipients 118
The control of muscle protein turnover in patients on peritoneal dialys 112
Testosterone deficiency, frailty and muscle wasting in CKD: a converging paradigm? 109
ACTIVATION OF THE NLRP3 INFLAMMASOME PROMOTES INFLAMMATION IN SKELETAL MUSCLE OF PATIENTS WITH CKD 105
Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study 101
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 101
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 100
Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A "liaison dangereuse"? 99
An Updated Focus on Immune Checkpoint Inhibitors and Tubulointerstitial Nephritis 96
Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy 95
INDOXYL SULFATE INDUCES FIBROSIS AND INFLAMMATION BY UPREGULATING HEAT SHOCK PROTEIN 90 (HSP 90) IN RENAL FIBROBLASTS 90
Myostatin/activin-a signaling in the vessel wall and vascular calcification 87
How to Overcome Anabolic Resistance in Dialysis-Treated Patients? 86
THE REGULATION OF ADIPONECTIN AND ITS RECEPTOR IN SKELETAL MUSCLE AND VISCERAL FAT IN PATIENTS WITH CKD: A ROLE IN MAINTAINING THE ANTI-INFLAMMATORY HOMEOSTASIS 85
Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease 83
Alterazioni dell’equilibrio acido-base 81
Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy 77
Central line-associated bloodstream infections in hemodialysis patients in the COVID-19 era 77
Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review 76
A Toll‐like receptor‐4/NLRP3 inflammasome pathway promotes inflammation in skeletal muscle of chronic kidney disease patients 76
Hyperkalemia-induced acute flaccid paralysis: a case report 75
Muscle protein turnover and low-protein diets in patients with chronic kidney disease 74
Nutritional Challenges in Pregnant Women with Renal Diseases: Relevance to Fetal Outcomes 73
Chapter 18 Wasting and cachexia in chronic kidney disease 72
WASTING IN PATIENTS WITH CKD AND DIABETES: THE ROLE OF MYOSTATIN 71
Myostatin: Basic biology to clinical application 68
Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy 67
Changes of Acute Kidney Injury Epidemiology during the COVID-19 Pandemic: A Retrospective Cohort Study 66
Adiponectin removal by the human kidney: A preliminary study 65
Cellular Senescence Is Associated with Faster Progression of Focal Segmental Glomerulosclerosis 61
SA-β-Gal in Kidney Tubules as a Predictor of Renal Outcome in Patients with Chronic Kidney Disease 60
Myostatin and the Balance between Positive and Negative Regulators of Muscle Mass in Patients with Chronic Kidney Disease Chapter 60
Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs 57
Testosterone Disorders and Male Hypogonadism in Kidney Disease 56
The Contribution of Muscle Innate Immunity to Uremic Cachexia 53
Visit-to-Visit Systolic Blood Pressure Variability Independently Predicts Cardiovascular Events in a Kidney Transplant Recipients' Cohort 48
The Evolving Scenario of COVID-19 in Hemodialysis Patients 48
null 44
Deciphering the Prognostic and Predictive Value of Urinary CXCL10 in Kidney Recipients With BK Virus Reactivation 43
Kidney Transplantation in a Patient Affected by Sickle Cell Trait: A Case Report and State-of-the-Art Review 43
Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes 41
Pathophysiology of Physical Exercise in Kidney Patients: Unveiling New Players- The Role of Myokines 40
null 36
Kidney transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia (VITT): Definitely feasible and safe? 28
Treatment of Chronic Kidney Disease: Moving Forward 15
A Pre-Clinical Study on the Use of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PEP 2-8 to Mitigate Ischemic Injury in a Rat Marginal Donor Model 5
Cognitive Disorders in Chronic Kidney Disease: We Are What We Eat 4
Totale 4.061
Categoria #
all - tutte 17.324
article - articoli 13.995
book - libri 0
conference - conferenze 1.435
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.894
Totale 34.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 12 9 27 19 23 28 14 25
2021/2022322 21 14 10 20 19 32 6 78 28 31 23 40
2022/2023510 30 48 5 40 77 71 11 46 98 16 52 16
2023/2024390 14 33 13 55 32 89 18 30 18 11 25 52
2024/20251.387 55 69 49 81 96 110 84 204 36 75 165 363
2025/2026749 229 48 231 233 8 0 0 0 0 0 0 0
Totale 4.061